Pro-Dex, Inc.

NasdaqCM PDEX

Pro-Dex, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2024: 15.25

Pro-Dex, Inc. Interest Coverage Ratio is 15.25 for the Trailing 12 Months (TTM) ending September 30, 2024, a 98.58% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Pro-Dex, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2023 was 7.68, a -25.98% change year over year.
Pro-Dex, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2022 was 10.37, a -25.86% change year over year.
Pro-Dex, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2021 was 13.99, a -54.87% change year over year.
Pro-Dex, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending September 30, 2020 was 31.00, a 64.84% change year over year.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

NasdaqCM: PDEX

Pro-Dex, Inc.

CEO	Mr. Richard Lee Van Kirk Jr.
IPO Date	Aug. 7, 1986
Location	United States
Headquarters	2361 McGaw Avenue
Employees	146
Sector	Health Care
Industries Medical Instruments

Description

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Key trends

Past 5 years